The MEng program is designed for high-potential individuals to bridge the gap between traditional undergraduate programs in life sciences and engineering and the skills required for a successful career in biopharmaceutical and biomanufacturing industries. Students will gain these skills via interactions with industry experts, practical sessions, professional trainings, internships, individual and team projects, independent and industry-led research projects, and traditional seminars and lectures.
The MEng program is an intensive two-year program housed within the Amgen Bioprocessing Center (ABC) at KGI. The program is designed to train students to become bioprocess engineering professionals employed within the biopharmaceutical industry.
All second year MEng students complete the capstone TDP, which provides students with real-world experience of taking a drug molecule candidate to a pharmaceutical therapy. Students work in teams to design a complete biomanufacturing process capable of producing commercial quantities of a drug substance or product. Teams are supervised by a panel of academic and industry experts. Each team works on a separate design project based on bioindustry best practice, methods, and techniques. At the end of the academic year, students present a report of their work.